Amedisys Inc (NASDAQ:AMED) shares, rose in value on Friday, June 20, with the stock price down by -0.44% to the previous day’s close as strong demand from buyers drove the stock to $97.46.
Actively observing the price movement in the last trading, the stock closed the session at $97.89, falling within a range of $97.35 and $98.0. The value of beta (5-year monthly) was 0.944 whereas the PE ratio was 36.07 over 12-month period. Referring to stock’s 52-week performance, its high was $98.95, and the low was $82.15. On the whole, AMED has fluctuated by 2.87% over the past month.
With the market capitalization of Amedisys Inc currently standing at about $3.20 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-23.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AMED’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 6.35, with the price of AMED currently trading nearly 2.24% and 3.14% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 68.14, while the 7-day volatility ratio is showing 0.36% which for the 30-day chart, stands at 0.68%. Furthermore, Amedisys Inc (AMED)’s beta value is 0.94, and its average true range (ATR) is 0.88.
A comparison of Amedisys Inc (AMED) with its peers suggests the former has fared considerably weaker in the market. AMED showed an intraday change of -0.44% in last session, and over the past year, it grew by 6.19%%.
Data on historical trading for Amedisys Inc (NASDAQ:AMED) indicates that the trading volumes over the past 10 days have averaged 0.47 and over the past 3 months, they’ve averaged 371.13K. According to company’s latest data on outstanding shares, there are 32.82 million shares outstanding.
Nearly 2.75% of Amedisys Inc’s shares belong to company insiders and institutional investors own 90.91% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.88 million shares as on 2025-05-30, resulting in a short ratio of 4.91. According to the data, the short interest in Amedisys Inc (AMED) stood at 582.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 2.48 million. The stock has risen by 7.35% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AMED stock heading into the next quarter.
